Skip to content
NEW: CREATE AN AI-ASSISTED TENDER IN 2 MINUTES — TRY IT FREE
Back to search
hameln pharma – Fertigung

Development, licensing, sterile manufacturing and distribution of generic injection and infusion medicines

hameln pharma Logo

hameln pharma gmbh

Hameln (Inselstraße 1, headquarters) · Hameln-Afferde (production) · Gloucester (UK) · Glostrup (DK) · Melbourne (AU)New on Amplifa

1890Founded (acquisition of the Raths-Apotheke pharmacy in
1950Founding of Pharmazeutische Fabrik Hameln
more than 140 million dosesDelivered to customers in 2024
over 65 active ingredientsProduct portfolio
11,000 m²Production area Lange Feld, Hameln-Afferde

Fourth-generation family-owned group

hameln pharma gmbh is a family-owned, internationally active pharmaceutical group in its fourth generation, headquartered in Hameln. The company specializes in the development, licensing and sterile manufacture of generic injection and infusion preparations; the portfolio comprises more than 65 active ingredients from the fields of analgesics (including opioids), anesthetics, sedatives, antiemetics, antidotes and antibiotics. The value chain extends from API production at the sister company in Slovakia, via ampoule filling and packaging at the Hameln-Afferde plant (approx. 11,000 m² of production space, including a compact ampoule system), to worldwide distribution. Customers include hospitals, pharmacies, ambulatory surgery centers, medical practices and palliative care facilities, particularly in intensive care, emergency, palliative and anesthesiology medicine. In 2024, more than 140 million doses were delivered to customers in over 45, respectively 50, countries.

Site
Hameln
Processes
Ampoule filling (Ampoule filling), Sterile manufacture (Sterile Manufacture), Packaging (Packaging), Quality control / Quality Control Laboratory, API production (active pharmaceutical ingredients, own API production at sister company in Slovakia), Contract manufacturing of ampoules, coated tablets and tablets (Contract manufacturing, since 1955), Development and registration (licensing-in) of generic injectables, Distribution/contract manufacturing historically (ampoules, dragées, tablets)
Materials
Opioids (active ingredients), Injection/infusion active ingredients (more than 65 different active ingredients: analgesics,, Injection/infusion active ingredients, Opioids
Founded
1890
Industries
Pharmaceutical industry (generic injectables), Hospitals, Pharmacies, Ambulatory surgery centers, Palliative care centers, Anesthesiology
  1. 01

    Development and registration (licensing-in) of generic injectables

  2. 02

    API production (sister company Slovakia)

  3. 03

    Sterile manufacture / ampoule filling

  4. 04

    Packaging (including Integrated Syringe Labels®)

  5. 05

    Quality control

  6. 06

    Distribution via own subsidiaries and partners in more than 45 countries

Active ingredients and dosage forms

INJ

Injection/infusion active ingredients

More than 65 active ingredients such as analgesics, anesthetics, sedatives, antiemetics, antidotes and antibiotics for sterile dosage forms.

OPIOID

Opioids

Core business of pain medicine since the acquisition of the Raths-Apotheke, the pharmacy of Sertürner's successor — the discoverer of morphine.

Locations

Standort Hameln (headquarters)

Hameln (headquarters)

DE

Headquarters of the group

Standort Hameln-Afferde (Lange Feld)

Hameln-Afferde (Lange Feld)

DE

Production site (Pharmazeutische Fabrik Hameln, founded 1950)

Materials
Injection/infusion preparations, ampoules
  • Compact ampoule system
  • Ampoule filling
  • Packaging lines
  • Quality control laboratory
Standort Gloucester (UK)

Gloucester (UK)

GB

Distribution company hameln pharma ltd serving the NHS, private hospitals and wholesalers

  • Own modern warehouse
Standort Glostrup (DK)

Glostrup (DK)

DK

Distribution company hameln pharma ApS (founded 2019)

Standort Melbourne (AU)

Melbourne (AU)

AU

Distribution company hameln pharma Pty Ltd (founded 2020)

Standort Further distribution companies

Further distribution companies

DE

Norway, Sweden, the Netherlands, Italy as well as a representative office in Taiwan

Products

Generic injection and infusion preparations
Generic injection and infusion preparationsAmpoule filling · hospitals, palliative and intensive care medicine

Inside the production

Company 2024
Company 2024
Locations worldwide
Locations worldwide
History of the family business
History of the family business
hameln pharma – corporate appearance
hameln pharma – corporate appearance
Locations worldwide
Locations worldwide

Industries

Pharmaceutical industry (generic injectables)HospitalsPharmaciesAmbulatory surgery centersPalliative care centersAnesthesiologyIntensive care and emergency medicineVeterinary medicine (historical)Medical practicesPalliative medicine

Processes & technical limits

ProcessesToleranceMax. partWeightLot sizeMaterials
Ampoule filling (Ampoule filling)Joining––––Ampoules (injection preparations)
Sterile manufacture (Sterile Manufacture)Joining––––Injection/infusion preparations
Packaging (Packaging)Assembly–––––
Quality control / Quality Control LaboratoryTesting–––––
API production (active pharmaceutical ingredients, own API production at sister company in Slovakia)Joining––––Active ingredients (including opioids)
Contract manufacturing of ampoules, coated tablets and tablets (Contract manufacturing, since 1955)Joining–––––
Development and registration (licensing-in) of generic injectablesEngineering–––––

3 Anlagen & Maschinen

MachineManufacturer / modelQuantityWorking areaYear builtSite
Compact ampoule system (first compact ampoule system)––––Hameln-Afferde (Lange Feld), Germany
Own modern warehouse (modern warehouse)––––Gloucester, United Kingdom
Production building / factory––11,000 m² in total (Lange Feld, three construction phases)–Hameln-Afferde, Germany

Additional services

Development and registration (licensing-in) of generic injectablesDistribution/contract manufacturing historically (ampoules, dragées, tablets)Pharmacovigilance (24-hour availability)Medical Affairs / drug informationIntelligent packaging design / ready-to-use products with Integrated Syringe Labels®Drug Safety / emergency serviceBusiness development / partnerships

Reference customers

UK National Health Service (NHS)private hospitals in Great BritainWholesalers
Try it now

Test Amplifa Marketplace – no appointment needed.

From a structured request to the right manufacturing partner: AI-assisted matching, verified suppliers and transparent metrics — sign up in minutes and start on your own.

Create your free account